Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice...

Area of Science:

• Pharmacology and Therapeutics
• Pain Management
• Rheumatology

Background:

• Musculoskeletal pain is a prevalent health concern impacting patient quality of life (QoL).
• Effective pain management is crucial to prevent long-term negative consequences.

Purpose of the Study:

• To evaluate the clinical efficacy of Nuberol Forte (paracetamol 650 mg + orphenadrine 50 mg) for musculoskeletal pain.
• To assess the impact of Nuberol Forte on patient QoL in routine Pakistani clinical practice.

Main Methods:

• A prospective, observational, multicenter study (NFORT-EFFECT) involving 399 patients.
• Pain intensity assessed via Visual Analog Scale (VAS); QoL measured using Muscle and Joint Measure (MJM) scale.
• Patients followed up one to two weeks post-treatment; adverse events (AEs) monitored.

Main Results:

• Significant reduction in mean pain scores observed post-treatment (p<0.05).
• Overall improvement in patient QoL reported.
• Only 10 patients experienced mild AEs (e.g., dry mouth, dizziness).

Conclusions:

• Nuberol Forte demonstrates effective pain management for musculoskeletal conditions.
• The combination therapy significantly improves patient QoL.
• Nuberol Forte exhibits a favorable safety profile with minimal AEs.